The preliminary results of EXPOBAR study

Obesity affects over 650 million individuals worldwide and it is a major public health problem. Bariatric surgery is the most effective treatment for severe obesity, resulting in significant weight reduction and improvement in obesity-related conditions. However, the weight loss achieved through bariatric surgery often correlates with a notable decrease in skeletal muscle. This correla-tion suggests an elevated risk of sarcopenia among patients after surgery. The aim of this study was to evaluate the effects of obesity and bariatric surgery on sarcopenia-related indicators and diagnosis before and after surgery. A total of 17 bariatric surgery patients were included in this prospective study. The parameters to diagnose sarcopenia were determined for each partic-ipant, based on EWGSOP2 and EASO/ESPEN consensuses. All evaluations were performed on the five moments of this study: before surgery and at 1, 6, 12 and 18 months after surgery.肥胖问题已波及全球超过6.5亿人口，成为一项重大的公共卫生挑战。对于重度肥胖患者，减重手术是最为有效的治疗方案，它能够显著降低体重并改善与肥胖相关的疾病状况。然而，通过减重手术实现的体重减轻通常伴随着骨骼肌的显著减少，这一相关性提示了术后患者发生肌肉减少症的风险增加。本研究旨在评估肥胖及减重手术对肌肉减少症相关指标及诊断在手术前后的影响。该研究为前瞻性研究，纳入了17名减重手术患者。每位参与者的肌肉减少症诊断参数均依据EWGSOP2及EASO/ESPEN的共识来确定。所有评估均在研究的五个关键时间点进行：手术前以及手术后的第1、6、12和18个月。